Stakeholder Perspectives on Addressing Adverse Events from Adjuvant Cancer Therapy: A Qualitative Study

  • Publication Date :
  • Publication Type : Journal Article
  • Author(s) : Syril D. Pettit, Pamela Silberman, Kristen Hassmiller Lich, Rebecca A. Kirch, Steven E. Lipshultz, Randall Teal, Ethan Basch
  • Journal Name : Cancer

With increasing survival rates, a growing population of patients with cancer have received or will receive adjuvant therapy to prevent cancer recurrences. Patients and caregivers will confront the complexities of balancing the preventative benefits of adjuvant therapy with possible near‐term or long‐term adverse events (AEs). Adjuvant treatment–related AEs (from minimal to severe) can impact therapeutic adherence, quality of life, emotional and physical health, and survival. However, to the authors' knowledge, limited information is available regarding how stakeholders use or desire to use adjuvant‐related AE information to inform the care of patients with cancer.

Full text online:

Contact Us

Health and Environmental Sciences Institute (HESI)
Phone: +1-202-659-8404
Fax: +1-202-659-3859

740 15th Street NW, Suite 600
Washington, DC 20005

Stay Informed

Sign up for our monthly e-newsletter.